Trial Outcomes & Findings for Analyses of Anemia in Very Low Birth Weight (VLBW) Infants. (NCT NCT05949788)

NCT ID: NCT05949788

Last Updated: 2025-01-27

Results Overview

The incidence of early onset sepsis in very low birth weigh (VLBW) infants with anemia of prematurity (AOP)

Recruitment status

COMPLETED

Target enrollment

146 participants

Primary outcome timeframe

through study completion, an average of 6 months

Results posted on

2025-01-27

Participant Flow

This was a retrospective study on the maternal and infant clinical and electronic records.146 extremely preterm infants with a gestational age of less than 28 weeks were admitted to Bao'an Women's and Children's Hospital affiliated with Jinan University and Longhua District Women's and Children's Hospital from January 1, 2020 to December 31, 2022.

45 extremely preterm infants were excluded due to severe birth deformity, twin-twin transfusion syndrome, neonatal hemolytic disease, death within 14 days after birth or transfer to another hospital.

Participant milestones

Participant milestones
Measure
Anemia Group
The very low birth weight (VLBW) infants meet the diagnostic criteria of neonatal anemia during hospitalization between January 2020 and January 2023. No intervention: Retrospect study, no direct intervention
Control Group
The very low birth weight (VLBW) infants are included without anemia during hospitalization between January 2020 and January 2023. No intervention: Retrospect study, no direct intervention
Overall Study
STARTED
36
110
Overall Study
COMPLETED
25
76
Overall Study
NOT COMPLETED
11
34

Reasons for withdrawal

Reasons for withdrawal
Measure
Anemia Group
The very low birth weight (VLBW) infants meet the diagnostic criteria of neonatal anemia during hospitalization between January 2020 and January 2023. No intervention: Retrospect study, no direct intervention
Control Group
The very low birth weight (VLBW) infants are included without anemia during hospitalization between January 2020 and January 2023. No intervention: Retrospect study, no direct intervention
Overall Study
severe birth deformity
2
7
Overall Study
twin-twin transfusion syndrome
2
7
Overall Study
neonatal hemolytic disease
3
8
Overall Study
death within 14 days after birth
2
6
Overall Study
transfer to another hospital
2
6

Baseline Characteristics

Race and Ethnicity were not collected from any participant.

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Anemia Group
n=25 Participants
The very low birth weight (VLBW) infants meet the diagnostic criteria of neonatal anemia during hospitalization between January 2020 and January 2023. No intervention: Retrospect study, no direct intervention
Control Group
n=76 Participants
The very low birth weight (VLBW) infants are included without anemia during hospitalization between January 2020 and January 2023. No intervention: Retrospect study, no direct intervention
Total
n=101 Participants
Total of all reporting groups
Age, Continuous
Gestational age
26 weeks (gestational age)
n=25 Participants
26.79 weeks (gestational age)
n=76 Participants
26.43 weeks (gestational age)
n=101 Participants
Sex: Female, Male
Female
11 Participants
n=25 Participants
28 Participants
n=76 Participants
39 Participants
n=101 Participants
Sex: Female, Male
Male
14 Participants
n=25 Participants
48 Participants
n=76 Participants
62 Participants
n=101 Participants
Race and Ethnicity Not Collected
0 Participants
Race and Ethnicity were not collected from any participant.
Region of Enrollment
China
25 participants
n=25 Participants
76 participants
n=76 Participants
101 participants
n=101 Participants

PRIMARY outcome

Timeframe: through study completion, an average of 6 months

The incidence of early onset sepsis in very low birth weigh (VLBW) infants with anemia of prematurity (AOP)

Outcome measures

Outcome measures
Measure
Anemia Group
n=25 Participants
The very low birth weight (VLBW) infants meet the diagnostic criteria of neonatal anemia during hospitalization between January 2020 and January 2023. No intervention: Retrospect study, no direct intervention
Control Group
n=76 Participants
The very low birth weight (VLBW) infants are included without anemia during hospitalization between January 2020 and January 2023. No intervention: Retrospect study, no direct intervention
The Incidence of Early Onset Sepsis in VLBW Infants With AOP.
Early onset sepsis
18 Participants
34 Participants
The Incidence of Early Onset Sepsis in VLBW Infants With AOP.
Non-early onset sepsis
7 Participants
42 Participants

SECONDARY outcome

Timeframe: Through study completion, an average of 6 months

The maternal hemoglobin (Hb) levels in very low birth weight (VLBW) infants with anemia of prematurity (AOP)

Outcome measures

Outcome measures
Measure
Anemia Group
n=25 Participants
The very low birth weight (VLBW) infants meet the diagnostic criteria of neonatal anemia during hospitalization between January 2020 and January 2023. No intervention: Retrospect study, no direct intervention
Control Group
n=76 Participants
The very low birth weight (VLBW) infants are included without anemia during hospitalization between January 2020 and January 2023. No intervention: Retrospect study, no direct intervention
The Maternal Hb Levels Before Birth Among VLBW Infants With AOP.
111 g/L
Interval 94.5 to 120.5
107 g/L
Interval 97.5 to 119.5

SECONDARY outcome

Timeframe: Through study completion, an average of 6 months

The incidence of death and morbidity among extremely preterm infants with AOP and without.

Outcome measures

Outcome measures
Measure
Anemia Group
n=25 Participants
The very low birth weight (VLBW) infants meet the diagnostic criteria of neonatal anemia during hospitalization between January 2020 and January 2023. No intervention: Retrospect study, no direct intervention
Control Group
n=76 Participants
The very low birth weight (VLBW) infants are included without anemia during hospitalization between January 2020 and January 2023. No intervention: Retrospect study, no direct intervention
Mortality and Morbidity Among Extremely Preterm Infants With Anemia of Prematurity (AOP)
moderate or severe BPD
7 Participants
20 Participants
Mortality and Morbidity Among Extremely Preterm Infants With Anemia of Prematurity (AOP)
ROP (greater than II)
12 Participants
39 Participants
Mortality and Morbidity Among Extremely Preterm Infants With Anemia of Prematurity (AOP)
NEC
3 Participants
6 Participants
Mortality and Morbidity Among Extremely Preterm Infants With Anemia of Prematurity (AOP)
Death
3 Participants
4 Participants
Mortality and Morbidity Among Extremely Preterm Infants With Anemia of Prematurity (AOP)
neonatal sepsis
17 Participants
39 Participants
Mortality and Morbidity Among Extremely Preterm Infants With Anemia of Prematurity (AOP)
IVH
7 Participants
16 Participants
Mortality and Morbidity Among Extremely Preterm Infants With Anemia of Prematurity (AOP)
EUGR
3 Participants
14 Participants

Adverse Events

Anemia Group

Serious events: 5 serious events
Other events: 20 other events
Deaths: 5 deaths

Control Group

Serious events: 10 serious events
Other events: 45 other events
Deaths: 10 deaths

Serious adverse events

Serious adverse events
Measure
Anemia Group
n=36 participants at risk
The very low birth weight (VLBW) infants meet the diagnostic criteria of neonatal anemia during hospitalization between January 2020 and January 2023. No intervention: Retrospect study, no direct intervention
Control Group
n=110 participants at risk
The very low birth weight (VLBW) infants are included without anemia during hospitalization between January 2020 and January 2023. No intervention: Retrospect study, no direct intervention
Infections and infestations
Death
5.6%
2/36 • Number of events 2 • "through study completion, an average of 6 months"
Two in anemia group and six in non-anemia group were excluded due to death within 14 days after birth. Three of 25 patients in anemia group were died, and four of 76 patients in non-anemia group were died. In anemia group: Two died from late onset sepsis, another died from necrotizing enterocolitis. In non-anemia group: Four died from late onset sepsis.
5.5%
6/110 • Number of events 6 • "through study completion, an average of 6 months"
Two in anemia group and six in non-anemia group were excluded due to death within 14 days after birth. Three of 25 patients in anemia group were died, and four of 76 patients in non-anemia group were died. In anemia group: Two died from late onset sepsis, another died from necrotizing enterocolitis. In non-anemia group: Four died from late onset sepsis.
Reproductive system and breast disorders
Death
5.6%
2/36 • Number of events 2 • "through study completion, an average of 6 months"
Two in anemia group and six in non-anemia group were excluded due to death within 14 days after birth. Three of 25 patients in anemia group were died, and four of 76 patients in non-anemia group were died. In anemia group: Two died from late onset sepsis, another died from necrotizing enterocolitis. In non-anemia group: Four died from late onset sepsis.
3.6%
4/110 • Number of events 4 • "through study completion, an average of 6 months"
Two in anemia group and six in non-anemia group were excluded due to death within 14 days after birth. Three of 25 patients in anemia group were died, and four of 76 patients in non-anemia group were died. In anemia group: Two died from late onset sepsis, another died from necrotizing enterocolitis. In non-anemia group: Four died from late onset sepsis.
Gastrointestinal disorders
Death
2.8%
1/36 • Number of events 1 • "through study completion, an average of 6 months"
Two in anemia group and six in non-anemia group were excluded due to death within 14 days after birth. Three of 25 patients in anemia group were died, and four of 76 patients in non-anemia group were died. In anemia group: Two died from late onset sepsis, another died from necrotizing enterocolitis. In non-anemia group: Four died from late onset sepsis.
0.00%
0/110 • "through study completion, an average of 6 months"
Two in anemia group and six in non-anemia group were excluded due to death within 14 days after birth. Three of 25 patients in anemia group were died, and four of 76 patients in non-anemia group were died. In anemia group: Two died from late onset sepsis, another died from necrotizing enterocolitis. In non-anemia group: Four died from late onset sepsis.

Other adverse events

Other adverse events
Measure
Anemia Group
n=36 participants at risk
The very low birth weight (VLBW) infants meet the diagnostic criteria of neonatal anemia during hospitalization between January 2020 and January 2023. No intervention: Retrospect study, no direct intervention
Control Group
n=110 participants at risk
The very low birth weight (VLBW) infants are included without anemia during hospitalization between January 2020 and January 2023. No intervention: Retrospect study, no direct intervention
Infections and infestations
Neonatal sepsis
47.2%
17/36 • Number of events 17 • "through study completion, an average of 6 months"
Two in anemia group and six in non-anemia group were excluded due to death within 14 days after birth. Three of 25 patients in anemia group were died, and four of 76 patients in non-anemia group were died. In anemia group: Two died from late onset sepsis, another died from necrotizing enterocolitis. In non-anemia group: Four died from late onset sepsis.
35.5%
39/110 • Number of events 39 • "through study completion, an average of 6 months"
Two in anemia group and six in non-anemia group were excluded due to death within 14 days after birth. Three of 25 patients in anemia group were died, and four of 76 patients in non-anemia group were died. In anemia group: Two died from late onset sepsis, another died from necrotizing enterocolitis. In non-anemia group: Four died from late onset sepsis.
Gastrointestinal disorders
NEC
8.3%
3/36 • Number of events 3 • "through study completion, an average of 6 months"
Two in anemia group and six in non-anemia group were excluded due to death within 14 days after birth. Three of 25 patients in anemia group were died, and four of 76 patients in non-anemia group were died. In anemia group: Two died from late onset sepsis, another died from necrotizing enterocolitis. In non-anemia group: Four died from late onset sepsis.
5.5%
6/110 • Number of events 6 • "through study completion, an average of 6 months"
Two in anemia group and six in non-anemia group were excluded due to death within 14 days after birth. Three of 25 patients in anemia group were died, and four of 76 patients in non-anemia group were died. In anemia group: Two died from late onset sepsis, another died from necrotizing enterocolitis. In non-anemia group: Four died from late onset sepsis.

Additional Information

Dr. Jun Luo

ShenzhenBMCHH

Phone: 015818671195

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place